Hemispherx Biopharma(HEB)2019-07-23 11:45
$Hemispherx Biopharma(HEB)$ 8-K - Current report Filed: 2019-07-22 AccNo: 0001493152-19-010919 Size: 319 KBItem 1.01: Entry into a Material Definitive AgreementItem 9.01: Financial Statements and Exhibits 网页链接查看全文
Hemispherx Biopharma(HEB)2019-07-23 11:45
$Hemispherx Biopharma(HEB)$ 424B5 - Prospectus [Rule 424(b)(5)] Filed: 2019-07-22 AccNo: 0001493152-19-010927 Size: 480 KB 网页链接查看全文
Hemispherx Biopharma(HEB)2019-06-29 00:30
$Hemispherx Biopharma(HEB)$ 8-K - Current report Filed: 2019-06-28 AccNo: 0001493152-19-009853 Size: 73 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain OfficersItem 9.01: Fin...查看全文
Nicole07772015-02-15 02:21
$HEMISPHERX BIOPHARMA INC(HEB)$ Hemispherx Biopharma and USAMRIID to Present New Discoveries Concerning the Efficacy of Ampligen(R) Against the Ebola Virus at Upcoming International Symposium on Filoviruses
网页链接查看全文
Nicole07772015-02-07 00:17
$HEMISPHERX BIOPHARMA INC(HEB)$ Biotech Stock Mailbag: Hep C stocks, Bluebird, Advaxis, Hemispherx
网页链接查看全文
Nicole07772015-02-05 23:45
$HEMISPHERX BIOPHARMA INC(HEB)$ Finally stop big reductions today. Now waitting big increase.[跪了]查看全文
Nicole07772015-02-03 01:27
$HEMISPHERX BIOPHARMA INC(HEB)$ "Tiny biotech says it may have an answer for Ebola[复盘][复盘][看多][能力圈]
Published: Feb 2, 2015 12:08 p.m. ET"
网页链接查看全文
Nicole07772015-02-02 23:49
$HEMISPHERX BIOPHARMA INC(HEB)$ Hemispherx: U.S. Army Scientists (USAMRIID) Find Ampligen(R) Produces 100% Survival Rate in Ebola Virus Rodent Study
网页链接查看全文
$Hemispherx Biopharma(HEB)$ 8-K - Current report Filed: 2019-08-26 AccNo: 0001493152-19-013386 Size: 83 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain OfficersItem 8.01: Oth...
$Hemispherx Biopharma(HEB)$ 8-K - Current report Filed: 2019-08-23 AccNo: 0001493152-19-013294 Size: 62 KBItem 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal YearItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Hemispherx Biopharma(HEB)$ DEF 14A - Other definitive proxy statements Filed: 2019-08-20 AccNo: 0001493152-19-013142 Size: 1 MB 网页链接
$Hemispherx Biopharma(HEB)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2019-08-14 AccNo: 0001493152-19-012572 Size: 5 MB 网页链接
$Hemispherx Biopharma(HEB)$ 8-K - Current report Filed: 2019-07-22 AccNo: 0001493152-19-010919 Size: 319 KBItem 1.01: Entry into a Material Definitive AgreementItem 9.01: Financial Statements and Exhibits 网页链接
$Hemispherx Biopharma(HEB)$ 424B5 - Prospectus [Rule 424(b)(5)] Filed: 2019-07-22 AccNo: 0001493152-19-010927 Size: 480 KB 网页链接
$Hemispherx Biopharma(HEB)$ SC 13D - General statement of acquisition of beneficial ownership Filed: 2019-06-28 AccNo: 0001493152-19-009885 Size: 54 KB 网页链接
$Hemispherx Biopharma(HEB)$ 8-K - Current report Filed: 2019-06-28 AccNo: 0001493152-19-009853 Size: 73 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain OfficersItem 9.01: Fin...
$Hemispherx Biopharma(HEB)$ 内部交易: 2019-06-27,Exec. 副Chairman/CEO/Pres.,EQUELS THOMAS K. ,买入,2632普通股, $4.37
$Hemispherx Biopharma(HEB)$ 内部交易: 2019-06-21,Director,MITCHELL WILLIAM M ,买入,9677普通股, $4.03